<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />

<meta name="author" content="F. Mendolia, K. Walkamp, K. Roth, T. Schmelter, C. Neumann, Z. Gao, A. Kaiser, S. Jeske, H. Kulmann" />

<meta name="date" content="2019-05-03" />

<title>dosedesignR</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>







<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">dosedesignR</h1>
<h4 class="author">F. Mendolia, K. Walkamp, K. Roth, T. Schmelter, C.
Neumann, Z. Gao, A. Kaiser, S. Jeske, H. Kulmann</h4>
<h4 class="date">May 3, 2019</h4>



<hr />
<div id="description" class="section level2">
<h2>Description</h2>
<p>The Shiny application dosedesignR provides the user with an
interactive application which can be used to facilitate the planning of
dose finding studies by applying the theory of optimal experimental
design. The application visualizes dose-response curves, optimal designs
and corresponding simulated realizations of dose-response studies.</p>
</div>
<div id="functionality" class="section level2">
<h2>Functionality</h2>
<p>After loading the package <code>dosedesignR</code>, the application
can be started by calling the function <code>run_dosedesignR()</code>
upon which the user interface opens. The user interface is split into
two parts: a sidebar panel on the left side for specifying general
options and the main panel for investigating different dose-response
relationships.</p>
<div id="left-sidebar-panel" class="section level3">
<h3>Left sidebar panel</h3>
<p>In the <em>Options</em> panel it is possible to specify the minimum
and maximum response as well as the minimum and maximum dose relevant
for the dose-response relationship. The default setting for the minimum
dose is 0, corresponding to placebo, which cannot be changed. The
response and dose options are mainly used for plotting, even though the
maximum dose is also a design parameter.</p>
<p>For the <em>Design Options</em> the total number of patients that
should be distributed across the different dose levels determined by the
optimal design can be entered. Furthermore, it is possible to choose
between two different dose restrictions for the optimal design: <em>Min
and max dose only</em> and <em>Specify dose levels</em>. For <em>Min and
max dose</em> only the optimal design is derived on the continuous
design space between the minimum and the maximum dose defined above.
These designs are theoretically optimal and calculated exactly. <em>For
Specify dose levels</em> specific dose levels need to be entered in the
<em>Dose levels panel</em> beneath (separated by semicolon) and the
optimal design is derived restricted to these entered dose levels. To
find the optimal designs an optimization algorithm selects among all
possible combinations of patients and dose levels. Additionally, the
underlying optimality criterion for the calculation of the optimal
design can be selected (in the current version this is restricted to
D-Optimality). Lastly, one can specify the population standard deviation
of the response and a confidence level. Both will be used for the
simulations in the main panel.</p>
</div>
<div id="main-panel" class="section level3">
<h3>Main panel</h3>
<p>The main panel is again split up into three vertical subpanels,
labeled as <em>Candidate Model 1</em>, <em>Candidate Model 2</em> and
<em>Candidate Model 3</em>. Thus it allows to simultaneously compare
three different dose-response models. So far the linear model, the emax
model and the sigmoidal emax model are implemented. Let <span class="math inline">\(d\)</span> denote the dose within the specified
dose range. Then the models are defined as follows</p>
<p><span class="math display">\[ \mathrm{response}_{lin}= E_0+Slope
\cdot d,\]</span> <span class="math display">\[
\mathrm{response}_{emax}=E_0 + \frac{E_{max} d }{ED_{50} + d},\]</span>
<span class="math display">\[ \mathrm{response}_{sig}=E_0 +
\frac{E_{max} d^h }{ED_{50}^h + d^h},\]</span> Here, <span class="math inline">\(d\)</span> denotes the dose, <span class="math inline">\(E_0\)</span> is the placebo response, <span class="math inline">\(E_{max}\)</span>is the maximal treatment effect,
<span class="math inline">\(ED_{50}\)</span> is the half effect dose,
i.e. the dose at which half of the maximal effect is reached, and <span class="math inline">\(h\)</span> is the Hill parameter which determines
the steepness of the response increase/decrease.</p>
<p>Each of the three vertical candidate panels consists of three parts:
a top part to choose the model parameters and plot the corresponding
dose-response curve, a middle part to visualize the optimal design and a
bottom part in which a user-defined design can be compared with the
optimal design.</p>
<p>In the top part, the values of the respective model parameters can be
entered in the <em>Parameters</em> tab. The <em>Plot</em> tab next to
the <em>Parameters</em> tab visualizes the dose-response curve based on
the chosen model and the corresponding model parameters.</p>
<p>In the middle part, the optimal design based on the chosen
dose-response model and corresponding parameter values is visualized by
black vertical lines, taking into account the number of patients, the
dose restrictions and the optimality criterion selected in the left
sidebar panel. Additionally, the optimal design is tabulated underneath
the plots.</p>
<p>In the bottom part, a user defined design can be entered by
specifying dose levels in the <em>Dose levels</em> input box and the
corresponding number of patients in the <em>Patients</em> input box
(separated by semicolon, respectively). The user defined design is
additionally visualized in the optimal design plot by green dots. The
user defined design is not bound by the dose restrictions selected in
the left sidebar panel and dose levels apart from these could be
specified. Underneath the input boxes for the user defined design the
properties of the design in tabular form are shown. In the first line,
the total number of patients entered is shown. In the second line the
efficiency of the user defined design compared to the optimal design
(under the chosen dose restrictions) is shown in percentage. In the last
line this efficiency is converted to the number of patients which would
additionally be needed to achieve the same precision in the parameter
estimation (O’Quigley et al., 2017).</p>
<p>By choosing the <em>Simulation</em> tab next to the
<em>Parameters</em> and <em>Plot</em> tab in the top part of the panel,
another plot appears. Here it is possible to visualize simulated
realizations of dose-response measurements and the corresponding effect
on the estimation of the dose-response curve. The underlying design,
i.e. the dose levels and the number of patients per dose level, can be
selected to be any of the three optimal designs or any of the three user
defined designs specified in the three candidate model panels. Response
realizations are randomly drawn from a normal distribution with mean
equal to the value of the true curve and variance based on the
population standard deviation specified in the left sidebar panel. The
true and the estimated curve together with the corresponding confidence
interval are shown. True curve here refers to the specified candidate
model in the corresponding panel.</p>
</div>
</div>
<div id="additional-information" class="section level2">
<h2>Additional information</h2>
<p>The application was optimized for display on a screen/projector with
HD resolution.</p>
</div>
<div id="disclaimer" class="section level2">
<h2>Disclaimer</h2>
<p>The authors do not guarantee the accuracy of any results.</p>
</div>
<div id="acknowledgements" class="section level2">
<h2>Acknowledgements</h2>
<p>The authors would like to thank the “dose finding group”” within
Bayer’s Biostatistics Innovation Center [1].</p>
<p>Besides other packages, the DoseFinding [2] package and the shiny [3]
package are extensively used within this dosedesignR package.</p>
</div>
<div id="references" class="section level2">
<h2>References</h2>
<ul>
<li>Kulmann H., Muysers C., Dmitrienko A. and Röhmel J. (2016). <em>The
Biostatistics Innovation Center at Bayer.</em> Biopharmaceutical Report
23, 1-5.</li>
<li>Bornkamp B., Pinheiro J. and Bretz F. (2016). <em>DoseFinding:
Planning and Analyzing Dose Finding Experiments.</em> R package version
0.9-15. <a href="https://CRAN.R-project.org/package=DoseFinding" class="uri">https://CRAN.R-project.org/package=DoseFinding</a>.</li>
<li>Winston Chang, Joe Cheng, JJ Allaire, Yihui Xie and Jonathan
McPherson (2018). <em>shiny: Web Application Framework for R.</em> R
package version 1.1.0. <a href="https://CRAN.R-project.org/package=shiny" class="uri">https://CRAN.R-project.org/package=shiny</a></li>
</ul>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
